Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Safety and Efficacy Study in pediatric subjects aged 9 to 17 years of age with suboptimal LV
EBD on non-contrast 2D echocardiography. Imaging modalities that are used throughout the
study in pediatric subjects represented those utilized in routine clinical practice in
adults.